Below are the most recent publications written about "Insurance, Medigap" by people in Profiles.
-
Wong J, Murray Horwitz M, Bertisch SM, Herzig SJ, Buysse DJ, Toh S. Trends in Dispensing of Zolpidem and Low-Dose Trazodone Among Commercially Insured Adults in the United States, 2011-2018. JAMA. 2020 12 01; 324(21):2211-2213.
-
Golberstein E, Walsh K, He Y, Chernew ME. Supplemental coverage associated with more rapid spending growth for Medicare beneficiaries. Health Aff (Millwood). 2013 May; 32(5):873-81.
-
Fung V, Mangione CM, Huang J, Turk N, Quiter ES, Schmittdiel JA, Hsu J. Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes. Health Serv Res. 2010 Apr; 45(2):355-75.
-
Cutler DM, Finkelstein A, McGarry K. Preference Heterogeneity and Insurance Markets: Explaining a Puzzle of Insurance. Am Econ Rev. 2008 May; 98(2):157-162.
-
Hsu J, Fung V, Price M, Huang J, Brand R, Hui R, Fireman B, Newhouse JP. Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs. JAMA. 2008 Apr 23; 299(16):1929-36.
-
Iezzoni LI, Ngo LH, Kinkel RP. Working-age persons with multiple sclerosis and access to disease-modifying medications. Mult Scler. 2008 Jan; 14(1):112-22.
-
Taylor EF, Chernew M, McLaughlin C. Do determinants of medicare supplemental coverage choice vary by income. J Health Soc Policy. 2006; 22(1):1-18.
-
McLaughlin CG, Chernew M, Taylor EF. Medigap premiums and Medicare HMO enrollment. Health Serv Res. 2002 Dec; 37(6):1445-68.
-
Federman AD, Adams AS, Ross-Degnan D, Soumerai SB, Ayanian JZ. Supplemental insurance and use of effective cardiovascular drugs among elderly medicare beneficiaries with coronary heart disease. JAMA. 2001 Oct 10; 286(14):1732-9.
-
Wilensky GR, Newhouse JP. Medicare: what's right? What's wrong? What's next? Health Aff (Millwood). 1999 Jan-Feb; 18(1):92-106.